{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:34:40Z","timestamp":1792427680812,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejim.2023.02.019","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:58:56Z","timestamp":1678409936000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1238-872X","authenticated-orcid":false,"given":"Roberto","family":"Pontremoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-1271","authenticated-orcid":false,"given":"Giovambattista","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-0883","authenticated-orcid":false,"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Temporelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Dovizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Degli","family":"Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejim.2023.02.019_bib0001","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiolog genetics and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"issue":"8311","key":"10.1016\/j.ejim.2023.02.019_bib0002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","article-title":"Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease","volume":"2","author":"Moorhead","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2023.02.019_bib0003","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1046\/j.1523-1755.1999.07109.x","article-title":"Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy","volume":"71","author":"Jandeleit-Dahm","year":"1999","journal-title":"Kidney Int Suppl"},{"issue":"8","key":"10.1016\/j.ejim.2023.02.019_bib0004","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","article-title":"Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes","volume":"54","author":"Wang","year":"2005","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.ejim.2023.02.019_bib0005","doi-asserted-by":"crossref","first-page":"18919","DOI":"10.1074\/jbc.M110650200","article-title":"Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus","volume":"277","author":"Sun","year":"2002","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.ejim.2023.02.019_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105787","article-title":"Cellular cholesterol transport proteins in diabetic nephropathy","volume":"9","author":"Tsun","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejim.2023.02.019_bib0007","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","article-title":"Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study","volume":"54","author":"Davis","year":"2011","journal-title":"Diabetologia"},{"issue":"22","key":"10.1016\/j.ejim.2023.02.019_bib0008","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/CIRCULATIONAHA.121.055560","article-title":"Benefits of icosapent ethyl across the range of kidney function in patients with established cardiovascular disease or diabetes: REDUCE-IT RENAL","volume":"144","author":"Majithia","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.02.019_bib0009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"issue":"10225","key":"10.1016\/j.ejim.2023.02.019_bib0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2023.02.019_bib0011","unstructured":"Agenzia Italiana del Farmaco (AIFA). Guideline for the classification and conduction of the observational studies on medicines. 2010. Available at: http\/\/www.aifa.gov.it\/-\/linee-guida-studi-osservazionali. Accessed march 2023."},{"issue":"20","key":"10.1016\/j.ejim.2023.02.019_bib0012","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the american heart association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ejim.2023.02.019_bib0020","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/dc16-1246","article-title":"Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabet Care"},{"issue":"10","key":"10.1016\/j.ejim.2023.02.019_bib0013","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","article-title":"Atherosclerosis in chronic kidney disease: more, less, or just different?","volume":"39","author":"Valdivielso","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2023.02.019_bib0014","first-page":"1648","volume":"380","author":"Mahmoodi","year":"2012"},{"issue":"9943","key":"10.1016\/j.ejim.2023.02.019_bib0015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ejim.2023.02.019_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015801","article-title":"Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk italian population: the TG-REAL retrospective cohort analysis","volume":"9","author":"Arca","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ejim.2023.02.019_bib0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2013.12.037","article-title":"Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population","volume":"233","author":"Tsuruya","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ejim.2023.02.019_bib0018","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/j.ajkd.2015.05.011","article-title":"Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of ckd: a longitudinal study in a large japanese population","volume":"66","author":"Tsuruya","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ejim.2023.02.019_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.jrn.2017.05.002","article-title":"Association of hypertriglyceridemia with the incidence and progression of chronic kidney disease and modification of the association by daily alcohol consumption","volume":"27","author":"Tsuruya","year":"2017","journal-title":"J Ren Nutr"},{"issue":"1","key":"10.1016\/j.ejim.2023.02.019_bib0021","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12882-021-02339-5","article-title":"Hypertriglyceridemic waist phenotype and risk of chronic kidney disease in community-dwelling adults aged 60\u2009years and older in Tianjin, China: a 7-year cohort study","volume":"22","author":"Chen","year":"2021","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.ejim.2023.02.019_bib0022","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/s41598-018-20907-y","article-title":"Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients","volume":"8","author":"Voskamp","year":"2018","journal-title":"Sci Rep"},{"issue":"24","key":"10.1016\/j.ejim.2023.02.019_bib0023","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejim.2023.02.019_bib0024","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneph.2009.184","article-title":"An update on the lipid nephrotoxicity hypothesis","volume":"5","author":"Ruan","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.ejim.2023.02.019_bib0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00041552-200405000-00010","article-title":"Impact of the renin-angiotensin system on lipid and carbohydrate metabolism","volume":"13","author":"Strazzullo","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"10.1016\/j.ejim.2023.02.019_bib0026","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejim.2023.02.019_bib0027","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.kint.2018.01.005","article-title":"Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice","volume":"93","author":"Rops","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2023.02.019_bib0028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clnesp.2019.12.001","article-title":"The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male","volume":"35","author":"Mansyur","year":"2020","journal-title":"Clin Nutr ESPEN"},{"issue":"5","key":"10.1016\/j.ejim.2023.02.019_bib0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11883-021-00918-3","article-title":"Lipid lowering drugs: present status and future developments","volume":"23","author":"Ruscica","year":"2021","journal-title":"Curr Atheroscler Rep"},{"issue":"10","key":"10.1016\/j.ejim.2023.02.019_bib0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jacc.2015.12.047","article-title":"Fasting or nonfasting lipid measurements: it depends on the question","volume":"67","author":"Driver","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2023.02.019_bib0031","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.ajkd.2005.03.002","article-title":"Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients","volume":"45","author":"Desmeules","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ejim.2023.02.019_bib0032","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"Improving global outcomes lipid guideline development work group members. KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523000596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523000596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:39:32Z","timestamp":1760607572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":32,"alternative-id":["S0953620523000596"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.02.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}